Standard BioTools's total assets for Q4 2025 were $567.75M, an increase of 5.21% from the previous quarter. LAB total liabilities were $143.46M for the fiscal quarter, a 2.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.